These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33129259)
1. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study. Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015. Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran. Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371 [TBL] [Abstract][Full Text] [Related]
4. Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates. Li H; Cameron B; Douglas D; Stapleton S; Cheguelman G; Butler T; Luciani F; Lloyd AR Vaccine; 2020 Apr; 38(16):3255-3260. PubMed ID: 32151462 [TBL] [Abstract][Full Text] [Related]
5. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs. Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran. Khademi N; Skakiba E; Khodadoust M; Khoramdad M Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study. SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A Int J Prison Health; 2023 Nov; 19(4):536-544. PubMed ID: 36757302 [TBL] [Abstract][Full Text] [Related]
8. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016. Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795 [TBL] [Abstract][Full Text] [Related]
9. [Prevalence of hepatitis B and C among prison population in Croatia]. Burek V; Horvat J; Susić E; Mikulić R Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906 [TBL] [Abstract][Full Text] [Related]
10. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system. Poulin C; Courtemanche Y; Serhir B; Alary M Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia. Tadesse K; Ayalew G; Million Y; Gelaw A PLoS One; 2024; 19(4):e0301973. PubMed ID: 38626232 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019. Moradi G; Alavian SM; Gholami F; Ramezani R; Ahangarzadeh L; Moradi Y; Sharafi H Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832678 [No Abstract] [Full Text] [Related]
13. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis. Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study. Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil. Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis. Mehmandoost S; Khezri M; Mousavian G; Tavakoli F; Mehrabi F; Sharifi H; Dolan K; Shokoohi M Public Health; 2022 Feb; 203():75-82. PubMed ID: 35032918 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072 [TBL] [Abstract][Full Text] [Related]
19. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities. Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R; Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248 [TBL] [Abstract][Full Text] [Related]
20. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]